{
    "clinical_study": {
        "@rank": "58586", 
        "arm_group": {
            "arm_group_label": "Post Discharge Formula", 
            "arm_group_type": "Experimental", 
            "description": "Babies will be given formula for first three months post discharge"
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to compare the post-discharge growth of preterm infants fed\n      with 2 different post discharge formulas."
        }, 
        "brief_title": "Comparison of Post-Discharge Growth of Premature Infants Using Two Different Formulas", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Premature Birth of Newborn", 
        "condition_browse": {
            "mesh_term": "Premature Birth"
        }, 
        "detailed_description": {
            "textblock": "Infants will be randomized upon discharge from the NICU. We will follow weight, height and\n      head circumference for three months following discharge, In addition any feeding\n      difficulties will be noted."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Preterm infants that are being fed only by formulas (mother chose not to breast feed,\n             or cannot breast feed).\n\n          2. Gestational week 30-34.\n\n        Exclusion Criteria:\n\n          1. Congenital major malformation (e.g. congenital heart disease).\n\n          2. Chromosomal abnormality (e.g. Down's syndrome)\n\n          3. Gastrointestinal morbidity: S/P abdominal surgery, S/P NEC\n\n          4. Milk allergy\n\n          5. Chronic disease (e.g. oxygen treatment)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "34 Weeks", 
            "minimum_age": "30 Weeks"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759134", 
            "org_study_id": "chammermanpdc"
        }, 
        "intervention": {
            "arm_group_label": "Post Discharge Formula", 
            "description": "Babies will be given either materna sensitive or similac neosure", 
            "intervention_name": "Post discharge formula", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Premature neonate", 
            "Post-discharge", 
            "Formula"
        ], 
        "lastchanged_date": "October 24, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Shaare Zedek Medical Center"
            }
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Comparison of Post-Discharge Growth of Premature Infants Using Two Different Formulas", 
        "overall_official": [
            {
                "affiliation": "Shaare Zedek Medical Center", 
                "last_name": "Alona Bin-Nun, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Shaare Zedek Medical Center", 
                "last_name": "Cathy Hammerman, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "Israel: Israeli Health Ministry Pharmaceutical Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "weight (kg), length (cm), head circumference (cm).", 
            "measure": "growth", 
            "safety_issue": "No", 
            "time_frame": "3 months post discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759134"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shaare Zedek Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shaare Zedek Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Bio-equivalence Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}